SELLAS Life Sciences Group, Inc. (SLS)

NASDAQ: SLS · Real-Time Price · USD

11.74

+0.41 (3.62%)

At close: Oct 2, 2026, 4:00 PM EDT

11.78

+0.04 (0.38%)

After-hours: Oct 2, 2026, 7:59 PM EDT

SELLAS Life Sciences Group Employees

SELLAS Life Sciences Group had 13 employees as of December 31, 2025. The number of employees decreased by 2 or -13.33% compared to the previous year.

Employees

Change (1Y)

-2

Growth (1Y)

-13.33%

Revenue / Employee

n/a

Profits / Employee

-$2,497,000

Market Cap

2.37B

Employees Chart

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	13	-2	-13.33%
Dec 31, 2024	15	-1	-6.25%
Dec 31, 2023	16	-1	-5.88%
Dec 31, 2022	17	6	54.55%
Dec 31, 2021	11	4	57.14%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro

Company Name	Employees
ADMA Biologics	647
Recursion Pharmaceuticals	600
Beam Therapeutics	540
Vera Therapeutics	361
Nurix Therapeutics	317
Harmony Biosciences Holdings	293
Viridian Therapeutics	252
Immunome	247